-
Je něco špatně v tomto záznamu ?
Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults
R. Chiesa, J. Wang, HJ. Blok, S. Hazelaar, B. Neven, D. Moshous, A. Schulz, M. Hoenig, F. Hauck, A. Al Seraihy, J. Gozdzik, P. Ljungman, CA. Lindemans, JF. Fernandes, K. Kalwak, B. Strahm, U. Schanz, P. Sedlacek, KW. Sykora, S. Aksoylar, F....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, multicentrická studie
NLK
Free Medical Journals
od 1946 do Před 1 rokem
Freely Accessible Science Journals
od 1946 do Před 1 rokem
Open Access Digital Library
od 1946-01-01
Open Access Digital Library
od 1946-01-01
ROAD: Directory of Open Access Scholarly Resources
PubMed
32614953
DOI
10.1182/blood.2020005590
Knihovny.cz E-zdroje
- MeSH
- chronická granulomatózní nemoc patologie terapie MeSH
- dítě MeSH
- dospělí MeSH
- homologní transplantace MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- míra přežití MeSH
- mladiství MeSH
- mladý dospělý MeSH
- následné studie MeSH
- předškolní dítě MeSH
- příprava pacienta k transplantaci MeSH
- prognóza MeSH
- retrospektivní studie MeSH
- transplantace hematopoetických kmenových buněk metody mortalita MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
Chronic granulomatous disease (CGD) is a primary immunodeficiency resulting in life-threatening infections and inflammatory complications. Allogeneic hematopoietic cell transplantation (allo-HCT) can cure the disease, but the indication to transplant remains controversial. We performed a retrospective multicenter study of 712 patients with CGD who underwent allo-HCT transplantation from March 1993 through December 2018. We studied 635 children (aged <18 years) and 77 adults. Median follow-up was 45 months. Median age at transplantation was 7 years (range, 0.1-48.6). Kaplan-Meier estimates of overall survival (OS) and event-free survival (EFS) at 3 years were 85.7% and 75.8%, respectively. In multivariate analysis, older age was associated with reduced survival and increased chronic graft-versus-host disease. Nevertheless, OS and EFS at 3 years for patients ≥18 years were 76% and 69%, respectively. Use of 1-antigen-mismatched donors was associated with reduced OS and EFS . No significant difference was found in OS, but a significantly reduced EFS was noted in the small group of patients who received a transplant from a donor with a >1 antigen mismatch. Choice of conditioning regimen did not influence OS or EFS. In summary, we report an excellent outcome after allo-HCT in CGD, with low incidence of graft failure and mortality in all ages. Older patients and recipients of 1-antigen-mismatched grafts had a less favorable outcome. Transplantation should be strongly considered at a younger age and particularly in the presence of a well-matched donor.
Children's Cancer Research Institute St Anna Children's Hospital Vienna Austria
Clinic of Hematology University Hospital Zurich Switzerland
Department of Bone Marrow Transplantation Hadassah University Hospital Jerusalem Israel
Department of Hematology Royal Hospital for Children Glasgow United Kingdom
Department of Paediatric Hematology and Oncology University Hospital Motol Prague Czech Republic
Department of Pediatrics and Adolescent Medicine University Medical Center Ulm Ulm Germany
Department of Pediatrics UMC Utrecht University Utrecht Utrecht The Netherlands
Department Pediatric Hematology Oncology Hannover Medical University Hannover Germany
European Society for Blood and Marrow Transplantation Data Office Leiden Leiden The Netherlands
Great Ormond Street Hospital for Children London United Kingdom
Hospital Israelita Albert Einstein São Paulo Brazil
Instituto da Criança Hospital das Clínicas da Universidade de São Paulo São Paulo Brazil
Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Pediatrico Bambino Gesù Rome Italy
Oncohematology and Bone Marrow Transplantation Unit Ospedale dei Bambini Brescia Italy
Pediatric BMT Centre Ege University Izmir Turkey
Pediatric Hematology Oncology Fondazione IRCCS Policlinico San Matteo Pavia Italy
Princess Maxima Center Utrecht The Netherlands
Unité d'Immunologie et d'Hématologie Hôpital Necker Paris France
Willem Alexander Kinderziekenhuis Leiden University Medical Center Leiden The Netherlands
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012158
- 003
- CZ-PrNML
- 005
- 20210713152053.0
- 007
- ta
- 008
- 210420s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1182/blood.2020005590 $2 doi
- 035 __
- $a (PubMed)32614953
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Chiesa, Robert $u Great Ormond Street Hospital for Children, London, United Kingdom
- 245 10
- $a Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults / $c R. Chiesa, J. Wang, HJ. Blok, S. Hazelaar, B. Neven, D. Moshous, A. Schulz, M. Hoenig, F. Hauck, A. Al Seraihy, J. Gozdzik, P. Ljungman, CA. Lindemans, JF. Fernandes, K. Kalwak, B. Strahm, U. Schanz, P. Sedlacek, KW. Sykora, S. Aksoylar, F. Locatelli, P. Stepensky, R. Wynn, SH. Lum, M. Zecca, F. Porta, M. Taskinen, B. Gibson, S. Matthes, M. Karakukcu, M. Hauri-Hohl, P. Veys, AR. Gennery, G. Lucchini, M. Felber, MH. Albert, D. Balashov, A. Lankester, T. Güngör, MA. Slatter
- 520 9_
- $a Chronic granulomatous disease (CGD) is a primary immunodeficiency resulting in life-threatening infections and inflammatory complications. Allogeneic hematopoietic cell transplantation (allo-HCT) can cure the disease, but the indication to transplant remains controversial. We performed a retrospective multicenter study of 712 patients with CGD who underwent allo-HCT transplantation from March 1993 through December 2018. We studied 635 children (aged <18 years) and 77 adults. Median follow-up was 45 months. Median age at transplantation was 7 years (range, 0.1-48.6). Kaplan-Meier estimates of overall survival (OS) and event-free survival (EFS) at 3 years were 85.7% and 75.8%, respectively. In multivariate analysis, older age was associated with reduced survival and increased chronic graft-versus-host disease. Nevertheless, OS and EFS at 3 years for patients ≥18 years were 76% and 69%, respectively. Use of 1-antigen-mismatched donors was associated with reduced OS and EFS . No significant difference was found in OS, but a significantly reduced EFS was noted in the small group of patients who received a transplant from a donor with a >1 antigen mismatch. Choice of conditioning regimen did not influence OS or EFS. In summary, we report an excellent outcome after allo-HCT in CGD, with low incidence of graft failure and mortality in all ages. Older patients and recipients of 1-antigen-mismatched grafts had a less favorable outcome. Transplantation should be strongly considered at a younger age and particularly in the presence of a well-matched donor.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a chronická granulomatózní nemoc $x patologie $x terapie $7 D006105
- 650 _2
- $a transplantace hematopoetických kmenových buněk $x metody $x mortalita $7 D018380
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a míra přežití $7 D015996
- 650 _2
- $a příprava pacienta k transplantaci $7 D019172
- 650 _2
- $a homologní transplantace $7 D014184
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Wang, Junfeng $u European Society for Blood and Marrow Transplantation (EBMT) Data Office Leiden, Leiden, The Netherlands ; Julius Center for Health Sciences and Primary Care, University Medical Center (UMC) Utrecht, Utrecht University, Utrecht, The Netherlands
- 700 1_
- $a Blok, Henric-Jan $u European Society for Blood and Marrow Transplantation (EBMT) Data Office Leiden, Leiden, The Netherlands
- 700 1_
- $a Hazelaar, Sheree $u European Society for Blood and Marrow Transplantation (EBMT) Data Office Leiden, Leiden, The Netherlands
- 700 1_
- $a Neven, Benedicte $u Unité d'Immunologie et d'Hématologie, Hôpital Necker, Paris, France
- 700 1_
- $a Moshous, Despina $u Unité d'Immunologie et d'Hématologie, Hôpital Necker, Paris, France
- 700 1_
- $a Schulz, Ansgar $u Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany
- 700 1_
- $a Hoenig, Manfred $u Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany
- 700 1_
- $a Hauck, Fabian $u Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
- 700 1_
- $a Al Seraihy, Amal $u Pediatric Hematology/Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
- 700 1_
- $a Gozdzik, Jolanta $u Department of Clinical Immunology and Transplantation, Jagiellonian University Medical College, Transplantation Center, University Children's Hospital, Krakow, Poland
- 700 1_
- $a Ljungman, Per $u Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden
- 700 1_
- $a Lindemans, Caroline A $u Department of Pediatrics, UMC Utrecht, University Utrecht, Utrecht, The Netherlands $u Princess Maxima Center, Utrecht, The Netherlands
- 700 1_
- $a Fernandes, Juliana F $u Instituto da Criança, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil $u Hospital Israelita Albert Einstein, São Paulo, Brazil
- 700 1_
- $a Kalwak, Krzysztof $u Division of Pediatric Hematology and Oncology Medical Center, Department of Pediatric Hematology/Oncology and BMT, Wroclaw Medical University, Wroclaw, Poland
- 700 1_
- $a Strahm, Brigitte $u Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- 700 1_
- $a Schanz, Urs $u Clinic of Hematology, University Hospital, Zurich, Switzerland
- 700 1_
- $a Sedlacek, Petr $u Department of Paediatric Hematology and Oncology, University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Sykora, Karl-Walter $u Department Pediatric Hematology/Oncology, Hannover Medical University, Hannover, Germany
- 700 1_
- $a Aksoylar, Serap $u Pediatric BMT Centre, Ege University, Izmir, Turkey
- 700 1_
- $a Locatelli, Franco $u Istituto di Ricovero e Cura a Carattere Scientifico (IRRCS), Ospedale Pediatrico Bambino Gesù, Rome, Italy
- 700 1_
- $a Stepensky, Polina $u Department of Bone Marrow Transplantation, Hadassah University Hospital, Jerusalem, Israel
- 700 1_
- $a Wynn, Robert $u Bone Marrow Unit, Department of Paediatric Hematology, Central Manchester National Health Service (NHS) Trust, Manchester, United Kingdom
- 700 1_
- $a Lum, Su Han $u Department of Paediatric Immunology, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom $u Willem-Alexander Kinderziekenhuis, Leiden University Medical Center, Leiden, The Netherlands
- 700 1_
- $a Zecca, Marco $u Pediatric Hematology-Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
- 700 1_
- $a Porta, Fulvio $u Oncohematology and Bone Marrow Transplantation (BMT) Unit, Ospedale dei Bambini, Brescia, Italy
- 700 1_
- $a Taskinen, Mervi $u Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Helsinki University Hospital, Helsinki, Finland
- 700 1_
- $a Gibson, Brenda $u Department of Hematology, Royal Hospital for Children, Glasgow, United Kingdom
- 700 1_
- $a Matthes, Susanne $u Children's Cancer Research Institute, St Anna Children's Hospital, Vienna, Austria
- 700 1_
- $a Karakukcu, Musa $u División of Pediatric Hematology and Oncology, Department of Pediatrics, Erciyes University, Kayseri, Turkey
- 700 1_
- $a Hauri-Hohl, Mathias $u Division of Stem Cell Transplantation, University Children's Hospital, Eleonore Foundation, Zurich, Switzerland
- 700 1_
- $a Veys, Paul $u Great Ormond Street Hospital for Children, London, United Kingdom
- 700 1_
- $a Gennery, Andrew R $u Department of Paediatric Immunology, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom $u Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; and
- 700 1_
- $a Lucchini, Giovanna $u Great Ormond Street Hospital for Children, London, United Kingdom
- 700 1_
- $a Felber, Matthias $u Division of Stem Cell Transplantation, University Children's Hospital, Eleonore Foundation, Zurich, Switzerland
- 700 1_
- $a Albert, Michael H $u Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
- 700 1_
- $a Balashov, Dmitry $u Department of Hematopoietic Stem Cell Transplantation, Dmitry Rogachev National Medical Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia
- 700 1_
- $a Lankester, Arjan $u Willem-Alexander Kinderziekenhuis, Leiden University Medical Center, Leiden, The Netherlands
- 700 1_
- $a Güngör, Tayfun $u Division of Stem Cell Transplantation, University Children's Hospital, Eleonore Foundation, Zurich, Switzerland
- 700 1_
- $a Slatter, Mary A $u Department of Paediatric Immunology, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom $u Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; and
- 773 0_
- $w MED00000807 $t Blood $x 1528-0020 $g Roč. 136, č. 10 (2020), s. 1201-1211
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32614953 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210713152050 $b ABA008
- 999 __
- $a ok $b bmc $g 1650517 $s 1132537
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 136 $c 10 $d 1201-1211 $e 20200903 $i 1528-0020 $m Blood $n Blood $x MED00000807
- LZP __
- $a Pubmed-20210420
